Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ibio Inc IBIO

iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu... see more

Bullboard (NYSEAM:IBIO)

View:
Comment by Patienceiskeeon Oct 13, 2020 11:36am

RE:I am not

I'm glad I decided to stay out of flipping this and just hold this for a little bit I think you're better off to stay away from flipping this for a while it looks like it's going to take ...more  
Post by Patienceiskeeon Oct 12, 2020 7:25pm

I am not

Usually a day trader but have made a lot of money trading this everyday. But I haven't the last couple. You seem to be able to tell from the pre-market or post-market what might be going to happen ...more  
Post by FelixFunon Oct 05, 2020 5:33am

iBio is part of the Manhattan Project for BioDefense ...

About iBio Inc. iBio, Inc. (NYSE MKT: IBIO), a leader in the ...more  
Comment by Patienceiskeeon Sep 29, 2020 3:40pm

RE:RE:RE:IBio

I was lucky enough to buy this at $2 and was able to tell it at $2.13. That's $0.11 US money. Not bad for one day but I wouldn't want to let this one go too long cuz it's going to pop soon ...more  
Comment by Patienceiskeeon Sep 29, 2020 8:28am

RE:IBio

Our prayers are coming true. I hope they manipulate the stock down another dime or two for I can afford to buy in
Post by Patienceiskeeon Sep 29, 2020 7:31am

IBio

With their proven booster technology and very renowned way of multiplying the vaccine. This will be the vaccine you can't end with. And with capacity already signed to produce a hundred million ...more  
Post by Patienceiskeeon Sep 28, 2020 10:52pm

We definitely need a vaccine in North America five

With the changing weather in the upcoming holidays in the u.s. and Canada things might get heated up over here quick. I ran into a very knowledgeable person the other day while flying told me I should ...more  
Post by Patienceiskeeon Sep 28, 2020 11:00am

Mr. Trump/ Mr. Trudeau

Sitting in the Toronto Pearson airport right now thinking to myself how empty it is! And how empty all the flights are! And the cabi the restaurants the hotels send soon-to-be empty home. And I'm ...more  
Post by Patienceiskeeon Sep 28, 2020 10:17am

Vaccine needed now

Hopefully iBio comes through! I was just thinking with a holiday in the u.s. today things might get heated up here tomorrow
Post by FelixFunon Sep 01, 2020 1:41pm

$IBIO involvement Guaranteed with DOD's Golden Mouse

DOD Golden Mouse Guarantees iBio will be producer. UAMRIID Dr. Golden replicates lethal ACE2 receptor mouse meaning if we can create it, we can cure it. DARPA 2012 $250M IDV Contracts to Fraunhofer ...more  
Post by FelixFunon Aug 31, 2020 7:44am

iBio Inc – A Key COVID-19 Vaccine Player

While other coronavirus stocks have been making big moves in April, iBio Stock (NYSEAMERICAN:IBIO) has been stuck trading just under the $1 level. With Aytu Bioscience Inc, Inovio Pharmaceuticals, and ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities